PharmGKB Blog
Friday, October 31, 2014

Clinical evidence support for biomarkers on FDA-approved drug labels

›
A recent article by Wang et al. in JAMA Internal Medicine reviews the clinical evidence support found on FDA-approved drug labels that are ...
Monday, October 27, 2014

ClinGen's GenomeConnect Patient Portal Launches

›
The NIH-funded Clinical Genome Resource (ClinGen) project has launched its patient portal at GenomeConnect .  This site provides a patient ...
Thursday, October 16, 2014

New pathway: Ibuprofen Pharmacodynamics

›
We have added a new pathway: ibuprofen PD pathway   to PharmGKB's pathway collections . Ibuprofen is a traditional non-steroidal anti...

PharmGKB Wikipedia page

›
PharmGKB now has a Wikipedia page. The page provides an overview of our purpose, as well as the types of content available on the website. ...
Wednesday, October 15, 2014

The genetics of warfarin dose: focus on African Americans

›
Warfarin has a narrow therapeutic window, therefore it is important to get the dosage for a patient correct - too low or too high a dose can...
Thursday, October 2, 2014

Gemcitabine pathway published in Pharmacogenetics and Genomics

›
Gemcitabine is a cancer drug used to treat solid tumors as well as certain blood cancers. It can be administered alone or in combination wit...
Wednesday, September 24, 2014

SNP-its Study Summaries

›
The University of Florida Health Personalized Medicine Program has released "SNP-its" study summaries for pharmacogenomic articl...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.